|Chemical and physical data|
|Molar mass||201.4 g/mol|
Tibulizumab (LY 3090106) (INN) is a humanized monoclonal antibody designed for the treatment of autoimmune diseases.
This drug was developed by Eli Lilly and Co.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|